Shengjun Fu
Impact in
-
- Pharmacological Effects of Natural Compounds
-
- Cancer, Lipids, and Metabolism
Papers in
-
- Renal and related cancers 4
- Epigenetics and DNA Methylation 3
- Surgery 6
- Bladder and Urothelial Cancer Treatments 4
- Co-authors
- You Luo (6 shared papers)Hu Xiong (5 shared papers)Zhiping Wang (15 shared papers)Li Yang (4 shared papers)Li Yang (1 shared paper)Jianzhong Lu (10 shared papers)Xuan Yuan (2 shared papers)Jirong Wang (3 shared papers)
- Journals
- Medicine (2 papers)PeerJ (2 papers)Chinese Medicine (2 papers)Renal Failure (1 paper)Biochemical Pharmacology (1 paper)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Shengjun Fu
35 papers receiving 410 citations
Peers
Comparison fields: 5 of 77
- Pharmacology 38
- Cancer Research 57
- Oncology 95
- Pulmonary and Respiratory Medicine 84
- Urology 12
Countries citing papers authored by Shengjun Fu
This map shows the geographic impact of Shengjun Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengjun Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengjun Fu more than expected).
Fields of papers citing papers by Shengjun Fu
This network shows the impact of papers produced by Shengjun Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengjun Fu. The network helps show where Shengjun Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shengjun Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 51 | |
| 2 | 2015 | 50 | |
| 3 | 2022 | 34 | |
| 4 | 2015 | 26 | |
| 5 | 2015 | 21 | |
| 6 | 2024 | 17 | |
| 7 | 2021 | 16 | |
| 8 | 2015 | 15 | |
| 9 | 2016 | 14 | |
| 10 | 2013 | 14 | |
| 11 | 2016 | 13 | |
| 12 | Effects of pollen extract EA-10, P5 on chronic prostatitis or infertility with chronic prostatitis. | 2002 | 12 |
| 13 | 2024 | 12 | |
| 14 | 2022 | 11 | |
| 15 | 2017 | 11 | |
| 16 | 2024 | 10 | |
| 17 | 2015 | 9 | |
| 18 | 2016 | 9 | |
| 19 | 2014 | 8 | |
| 20 | 2021 | 8 |
About Shengjun Fu
Shengjun Fu is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 36 papers that have together received 419 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (5 papers), Renal and related cancers (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Cancer Research and Treatments (4 papers), Virus-based gene therapy research (4 papers), Cancer, Lipids, and Metabolism (3 papers), Epigenetics and DNA Methylation (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Pharmacology (38 citations), Cancer Research (57 citations), Oncology (95 citations), Pulmonary and Respiratory Medicine (84 citations) and Urology (12 citations). Shengjun Fu has collaborated with scholars based in China, United States and Norway. Frequent co-authors include You Luo, Hu Xiong, Zhiping Wang, Li Yang, Li Yang, Jianzhong Lu, Xuan Yuan, Jirong Wang, Lu Gan and Zhenhua Wang. Their work appears in journals such as Medicine, PeerJ, Chinese Medicine, Renal Failure and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.